Haemonetics Corp (NYSE:HAE)
$ 83.51 -1.75 (-2.05%) Market Cap: 4.19 Bil Enterprise Value: 5.21 Bil PE Ratio: 34.65 PB Ratio: 4.79 GF Score: 76/100

Haemonetics Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 05:45PM GMT
Release Date Price: $83.23 (-2.29%)
Unidentified Participant

Hello everyone, thank you for joining today. It's my pleasure to introduce Haemonetics. Today, we'll be joined by Chris Simon, CEO, who'll go through a presentation, which will be followed by a short Q&A, which will also be supported by James D'Arecca, CFO; and Olga Guyette, Head of IR and Treasury. Thank you.

Chris Simon Haemonetics Corp.;President;CEO

&

Thank you, Zack, and thank you to JPMorgan Bank. I was reflecting on my flight out here; this is actually my 20th JPMorgan conference, the last seven of which have been with Haemonetics. Outstanding conference, and we see great value in being here, so thank you for the invitation.

Good morning, everyone, and we're pleased to be here, clearly. And we appreciate those of you here in the room with us but also those who have dialed in. I'm going to give you a brief overview of the company and our goals, and hopefully, you find it as exciting as we do.

Importantly, my remarks will include forward-looking statements and non-GAAP numbers, so our usual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot